Unlike GLP-1 agonists such as semaglutide or tirzepatide, which work primarily through appetite suppression, AOD-9604 directly enhances fat metabolism at the cellular level through beta-3 adrenergic receptor modulation
The target is metabolic: insulin sensitivity, visceral and liver fat, lipids, the markers of metabolic health rather than a number on the scale
Clinical evidence for weight loss in nutrient-replete individuals is limited
Its sourced from non-animal products and is known for its sustained benefits and popularity among vegans seeking effective B12 supplementation
For almost a century, not one harmful case of overdose has been recorded in medical literature
Injections: For dogs with severe deficiencies or malabsorption issues, veterinarians often recommend B12 injections, which are given under the skin for more direct delivery